Johns Hopkins researchers identify new CRC biomarker — 4 insights

Baltimore-based Johns Hopkins researchers discovered a potential colorectal cancer biomarker.

Here's what you should know:

1. The beta-1,4-galactosyltransferase-V protein increased in human CRC tumor cells, but not in healthy tissue.

2. As the protein's activity increased, its resulting product, lactosylceramide, led to the creation of new cells and blood vessels that can spread cancer.

3. When researchers stopped the protein, it halted CRC proliferation.

4. Researchers published their findings in Biochemical and Biophysical Research Communication.

More articles on gastroenterology:
The PE arms race — From the deal heard round the world to what's next in GI
The strategy behind Pardee UNC's $16M ASC
ASC supply chain tip of the day: Find an accountability structure

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast